This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: MediPharm Labs Corp.
Today announced its financial results for the three months ended June 30, 2025. Q2 Revenue was $11.8 Million, an Increase of 14% over Q2 2024. Cash balance was $10.4 Million at the end of Q2, Increased from $8.4 Million in Q1 2025. MediPharm Labs Corp. shares T.LABS are trading down $0.02 at $0.08.
